Status:
UNKNOWN
Contrast Sensitivity in Glaucoma
Lead Sponsor:
University of Erlangen-Nürnberg
Conditions:
Primary Open Angle Glaucoma
Secondary Open Angle Glaucoma Due to PEX
Eligibility:
All Genders
18+ years
Brief Summary
The primary aim of the Erlangen´s Glaucoma Contrast Sensitivity-Study (EGCS-Study) is the evaluation of the diagnostic and prognostic validity of a diagnostic procedure, measuring contrast sensitivity...
Eligibility Criteria
Inclusion
- Patients: Primary open angle glaucoma, secondary open angle glaucoma due to PEX
- Healthy volunteers (for reliability analysis)
- Age \> 18
- Best corrected visual acuity 0.8 or better
- European
Exclusion
- eye diseases: Infantile glaucoma, angle glaucoma, secondary open angle glaucoma, wich are not due to PEX, diseases involving retina, condition after ophthalmological operations or trauma, cataract, diseases concerning the refractive system, age-related macular degeneration, diabetic retinopathy, optic neuropathy (MS, neuritis), amblyopia
- Any neurological diseases
- Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)
- Systemic drugs with potentially ocular involvement
- ocular drugs
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00947869
Start Date
April 1 2009
Last Update
July 28 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Eye Hospital
Erlangen, Bavaria, Germany, 91054